Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Pembrolizumab 200, Head and Neck Tumors, first-line

Protocol-ID: 1445 V1.0 (Mini), PEMB200, Head and Neck Tumors, first-line

Indication(s)

  • Head and Neck Tumors (Squamous Cell) (PD-L1 with CPS from 1); ICD-10 C76.0
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 02.03.2020